1,597 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 680 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5381,597 (+59)

1.05% more ownership

Funds ownership: 78.09%79.15% (+1.1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,597
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.72B
2 +$2.26B
3 +$592M
4
Barclays
Barclays
United Kingdom
+$248M
5
Goldman Sachs
Goldman Sachs
New York
+$164M

Top Sellers

1 -$1.36B
2 -$392M
3 -$151M
4
Primecap Management
Primecap Management
California
-$148M
5
O
OrbiMed
New York
-$148M
Name Holding Trade Value Shares
Change
Change in
Stake
1201
$530K
1202
$529K
1203
$529K
1204
$528K
1205
$528K
1206
$526K
1207
$525K
1208
$525K
1209
$517K
1210
$514K
1211
$513K
1212
$513K
1213
$512K
1214
$511K
1215
$509K
1216
$507K
1217
$501K
1218
$499K
1219
$497K
1220
$496K
1221
$495K
1222
$492K
1223
$492K
1224
$487K
1225
$486K